FINGER PRICK CAPILLARY MIR-122 IS A BIOMARKER OF PARACETAMOL HEPATOTOXICITY

被引：0
|
作者：
Cirronis, M. [1 ,2 ]
Masini, E. [1 ,2 ]
Schneemann, S. [3 ]
Pettie, J. [4 ]
Eddleston, M. [3 ,4 ]
Dear, J. W. [3 ,4 ]
机构：
[1] Univ Florence, Sect Pharmacol & Toxicol, Dept Neurosci Psychiat Drug Area & Child Hlth NEU, Florence, Italy
[2] Careggi Univ, Gen Hosp, Florence Clin Toxicol, Florence, Italy
[3] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Pharmacol Toxicol & Therapeut, Edinburgh, Midlothian, Scotland
[4] Royal Infirm Edinburgh NHS Trust, Edinburgh Clin Toxicol, Edinburgh, Midlothian, Scotland
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2018年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P116
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Finger prick capillary microRNA-122 is a biomarker of paracetamol hepatotoxicity
    Cirronis, Marco
    Masini, Emanuela
    Schneemann, Sarah
    Pettie, Janice M.
    Eddleston, Michael
    Dear, James W.
    CLINICAL TOXICOLOGY, 2018, 56 (06) : 545 - 545
  • [2] Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity
    Cirronis, Marco
    Schneemann, Sarah
    Pettie, Janice
    Mannaioni, Guido
    Dear, James W.
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [3] Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies
    Sharapova, T.
    Devanarayan, V.
    LeRoy, B.
    Liguori, M. J.
    Blomme, E.
    Buck, W.
    Maher, J.
    VETERINARY PATHOLOGY, 2016, 53 (01) : 211 - 221
  • [4] Circulating miR-122 as a potential biomarker of liver disease
    Laterza, Omar F.
    Scott, Mitchell G.
    Garrett-Engele, Philip W.
    Korenblat, Kevin M.
    Lockwood, Christina M.
    BIOMARKERS IN MEDICINE, 2013, 7 (02) : 205 - 210
  • [5] The Ratio of miR-122 to miR-20a (miR-122/miR-20a) Is a Useful Minimally Invasive Biomarker for Non-Alcoholic Fatty Liver Disease Detection
    Hattori, Yuji
    Yamada, Hiroya
    Munetsuna, Eiji
    Fujii, Ryosuke
    Ando, Yoshitaka
    Yamazaki, Mirai
    Mizuno, Genki
    Tsuboi, Yoshiki
    Ishihara, Yuya
    Ichino, Naohiro
    Sugimoto, Keiko
    Osakabe, Keisuke
    Ishikawa, Hiroaki
    Ohashi, Koji
    Suzuki, Koji
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2023, 27 (08) : 239 - 247
  • [6] The Impact of miR-122 on Cancer
    Wu, Shijie
    Wu, Yiwen
    Deng, Sijun
    Lei, Xiaoyong
    Yang, Xiaoyan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (12) : 1489 - 1499
  • [7] Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
    Israelow, Benjamin
    Mullokandov, Gavriel
    Agudo, Judith
    Sourisseau, Marion
    Bashir, Ali
    Maldonado, Andres Y.
    Dar, Arvin C.
    Brown, Brian D.
    Evans, Matthew J.
    NATURE COMMUNICATIONS, 2014, 5
  • [8] Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
    Benjamin Israelow
    Gavriel Mullokandov
    Judith Agudo
    Marion Sourisseau
    Ali Bashir
    Andres Y. Maldonado
    Arvin C. Dar
    Brian D. Brown
    Matthew J. Evans
    Nature Communications, 5
  • [9] RNAi Induced Hepatotoxicity Results from a Functional Depletion of the First Synthesized Isoform of miR-122
    Valdmanis, Paul N.
    Gu, Shuo
    Chu, Kirk
    Jin, Lan
    Zhang, Feijie
    Munding, Elizabeth M.
    Zhang, Yue
    Huang, Yong
    Kutay, Huban
    Ghoshal, Kalpana
    Lisowski, Leszek
    Kay, Mark A.
    MOLECULAR THERAPY, 2016, 24 : S290 - S291
  • [10] Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjects
    Waring, J. F.
    Dumas, E. O.
    Abel, S.
    Coakley, E.
    Cohen, D. E.
    Davis, J. Wade
    Podsadecki, T.
    Dutta, S.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (02) : 96 - 104
12345